Literature DB >> 6291338

In-vitro secretion of ACTH in Nelson's syndrome.

D K Lüdecke, M Schabet, M Westphal, W Saeger.   

Abstract

Cell suspensions of ACTH cell adenomas of 10 patients with Nelson's syndrome were investigated for in-vitro secretion of ACTH. Two incubation systems, one using incubation beakers and the other a superfusion system, were employed. The cells were tested for their reactivity to lysine-vasopressin (LVP), cortisol, and combinations of both. LVP regularly provoked a rapid significant increase of ACTH secretion. The effect of cortisol was heterogeneous. Paradoxical initial stimulatory effects of cortisol were observed. There was a suppressive effect in some patients, which correlates to low proliferative activity in histological evaluation. In both systems a low secretory activity coincided with high proliferative activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291338     DOI: 10.1007/bf01405438

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  24 in total

1.  ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome.

Authors:  D H NELSON; J W MEAKIN; G W THORN
Journal:  Ann Intern Med       Date:  1960-03       Impact factor: 25.391

2.  Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism.

Authors:  H L Fehm; K H Voigt; G Kummer; R Lang; E F Pfeiffer
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Cyproheptadine in the treatment of Nelson's syndrome.

Authors:  W Hartwig; A Kasperlik-Załuska; J Wilczyńska; B Migdalska; K Czechowicz-Janicka; J Załuska
Journal:  Endokrynol Pol       Date:  1979 Mar-Apr       Impact factor: 1.582

4.  [Ultrastructure of hyperplastic and adenomatous corticotrophic cells in Cushing's syndrome of hypothalamic-hypophyseal origin (author's transl)].

Authors:  W Saeger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

5.  [Study of plasma ACTH in 100 human lysine-vasopressin tests].

Authors:  M Binoux; M Gourmelen-Combourieu; J P Luton; F Girard; M T Pham-Huu-Trung
Journal:  Acta Endocrinol (Copenh)       Date:  1971-09

6.  Corticotrophin releasing factor may be modulated vasopressin.

Authors:  G Gillies; P Lowry
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

Review 7.  Pathophysiology of Cushing's disease.

Authors:  H L Fehm; K H Voigt
Journal:  Pathobiol Annu       Date:  1979

8.  Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.

Authors:  S Oki; K Nakao; I Tanaka; K Horii; Y Nakai; S Shimbo; M Watanabe; T Nakane; A Kuwayama; N Kageyama; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

9.  Evidence of vasopressin in adenohypophysis: research into its role in corticotrope activity.

Authors:  M Chateau; J Marchetti; A Burlet; M Boulange
Journal:  Neuroendocrinology       Date:  1979       Impact factor: 4.914

10.  Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome.

Authors:  D T Krieger; M Luria
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

View more
  2 in total

1.  Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.

Authors:  M Westphal; P Jaquet; C B Wilson
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Pituitary microadenomas: surgical results and morphological findings.

Authors:  M Scanarini; S Mingrino; M Boscaro; N Sicolo; E Serafini; D Billeci
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.